The video is of a conference I hosted in South Wales in May 2019. I wrote a companion book to go with it:
Taming the BIG PHARMA Monster by Speaking Truth to Power.
Ironically, the COVID scam was just around the corner, unbeknown to me or any of us here. I’d been calling out the failing business model for 10 years and more, to the people I was working with. It seemed clear to me—a company can’t outsource all its manufacturing and distribution assets (people and facilities) and expect to be able to bring products to market. The only tools left in their box were patent monopolies and sales & marketing muscle.
Then, the valley of death emerged (new products failing to get to market) and the patent cliff kicked in (patents expiring). So mega mergers began, to disguise the damage. It only lasted so long, because without a supply chain capability it was always going to bite them on the bum.
In response, they bit their customers back, in an unbelievably vicious way. They converted dangerous gene theapies that were not selling into VACCINES. You know the rest :O(
Surely, history will vote this the greatest crime against humanity ever.
While the perpetrators are being brought to book: Gates; Fauci; Farrar; Vallance; Whitty; Ferguson—fill in your own blanks—I will be working on a solution that does not involve Big Pharma.
In part, it is based on the white paper I wrote following the conference, below:
MEDICINES FOR THE 21st CENTURY: Safe, Better, Cheaper
It is 60 pages, so you may not want to read the whole thing! This is the aim:
Aim
This paper is presented in the context of rapidly increasing volume and intensity of calls for major reform of companies developing and supplying medicines into healthcare systems (pharmaceutical companies). The modus operandi of those companies appears to be working against the best interests of those using their products – patients and healthcare professionals.
On May 8th, 2019, a group of clinicians, patients, representatives of relevant charities, experts in product development, legal, regulatory and supply chain specialists gathered together in Wales, with the aim of examining that claim, based on facts and evidence.
The day was organised in conference format, titled “MEDICINES FOR THE 21st CENTURY: Safe, Better, Cheaper”. It involved in-depth dialogue and transfer of knowledge, over three panel sessions, between invited attendees and panel members, considering issues and opportunities in relation to safe medicines, better medicines and cheaper medicines. Proceedings over the day were recorded on video, and live polling was used to collect inputs from those in attendance.
Along with this, I have been commissioned by the Hoboken, NJ headquartered academic publisher Wiley, to write a second book, titled:
Transforming the Pharmaceutical Supply Chain:
The aim is to educate current and future generations of graduates, researchers, and professionals, in a person-centred approach to medicines, with the underpinning assumptions:
Underpinning Assumptions for the New Model
The suggested approach assumes that a person, in the most basic of terms, is a hugely complex system, the internal workings of which are way beyond our understanding. Health is determined by the body that Mother Nature bestowed upon us at birth. The less interference there is with Mother Nature’s creation, the better. If illness does come our way, the body has its own way of dealing with it in the majority of cases, if left to its own devices. Hence the doctor’s Hippocratic Oath: “Primum non nocere” or "First, do no harm."
We assume that a doctor’s role is to focus initially on maintaining the health and wellbeing of prospective patients, aimed at preventing health issues. If a person’s health does not appear to be resolved by the body, diagnosis of a possible illness is the next stage. The quality of that diagnosis rests on doctors and the diagnostic tools available to them. The importance of advances in the diagnosis of disease is therefore paramount. A remedy for a patient is useless if they do not know they have a condition that needs medical attention.
Following diagnosis of a health condition, doctors normally have treatment alternatives. If the diagnosis uncovers lack of one or more vitamins or minerals, then a functional medicine route would likely be most appropriate. That will allow a treatment regimen to be identified and the patient’s progress monitored…
…and so it goes.
As a subscriber to INSIDE PHARMA, you will join me on the journey, so long as it is of interest.
MEDICINES FOR THE 21st CENTURY: Safe, Better, Cheaper